Home › Focal Segmental Glomerulosclerosis › Florida
Focal Segmental Glomerulosclerosis clinical trials in Florida
7 studies for Focal Segmental Glomerulosclerosis are looking for participants at sites in Florida.
Cities in Florida
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- University Of South Florida - Parent- Site Number : 8400025, Tampa
RecruitingPhase 2
Ages 16 to 75 · All sexes · Updated Sep 23, 2026 · NCT06500702A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
- Florida Kidney Physicians - Boca Raton, Boca Raton
- Florida Kidney Physicians, LLC - Fort Lauderdale, Fort Lauderdale
- Total Research Group, LLC, Miami
- and 3 more
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 17, 2026 · NCT07220083A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #17, Boca Raton
- Investigator Site #6, Coral Springs
- Investigator Site #25, Hialeah
- and 2 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 13, 2026 · NCT07268638Nephrotic Syndrome Study Network
- University of Miami Miller School of Medicine, Miami
RecruitingObservational study
Up to age 80 · All sexes · Updated Jun 10, 2026 · NCT01209000Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- University of Miami, Leonard M. Miller School of Medicine, Miami
- Nicklaus Children's Hospital, Miami
RecruitingPhase 2
Ages 1 to 17 · All sexes · Updated May 12, 2026 · NCT05003986A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
- Nicklaus Children's Hospital, Miami
- CTR Oakwater LLC, Orlando
RecruitingPhase 3
Ages 12 to 80 · All sexes · Updated Feb 3, 2026 · NCT05183646Proteinuria in Pre and Post Transplant
- University of Miami Miller School of Medicine Transplant Clinic, Miami
RecruitingObservational study
Up to age 25 · All sexes · Updated Nov 21, 2025 · NCT01094327From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.